Curcumin Binding to Beta Amyloid: A Computational Study

Chemical Biology & Drug Design
Praveen P N RaoGary Tin

Abstract

Curcumin, a chemical constituent present in the spice turmeric, is known to prevent the aggregation of amyloid peptide implicated in the pathophysiology of Alzheimer's disease. While curcumin is known to bind directly to various amyloid aggregates, no systematic investigations have been carried out to understand its ability to bind to the amyloid aggregates including oligomers and fibrils. In this study, we constructed computational models of (i) Aβ hexapeptide (16) KLVFFA(21) octamer steric-zipper β-sheet assembly and (ii) full-length Aβ fibril β-sheet assembly. Curcumin binding in these models was evaluated by molecular docking and molecular dynamics (MD) simulation studies. In both the models, curcumin was oriented in a linear extended conformation parallel to fiber axis and exhibited better stability in the Aβ hexapeptide (16) KLVFFA(21) octamer steric-zipper model (Ebinding  = -10.05 kcal/mol) compared to full-length Aβ fibril model (Ebinding  = -3.47 kcal/mol). Analysis of MD trajectories of curcumin bound to full-length Aβ fibril shows good stability with minimum Cα-atom RMSD shifts. Interestingly, curcumin binding led to marked fluctuations in the (14) HQKLVFFA(21) region that constitute the fibril spine with RMSF value...Continue Reading

References

Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ehud Gazit
Jan 6, 2004·Journal of Neuroscience Research·Ruitian LiuMichael R Sierks
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Jun 16, 2007·Advances in Experimental Medicine and Biology·Bharat B AggarwalHaruyo Ichikawa
Dec 27, 2008·Trends in Pharmacological Sciences·Bharat B Aggarwal, Bokyung Sung
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·Danielle G SmithKevin J Barnham
Apr 22, 2010·CNS Neuroscience & Therapeutics·Tsuyoshi HamaguchiMasahito Yamada
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anders SandbergTorleif Härd
Jun 23, 2011·PLoS Biology·Meytal LandauDavid Eisenberg
Nov 22, 2011·Nature Chemical Biology·Jan BieschkeErich E Wanker
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·James C StroudDavid Eisenberg
Jun 14, 2012·The Journal of Physical Chemistry. B·Li Na ZhaoYuguang Mu
Dec 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Cong LiuDavid Eisenberg
May 1, 2013·Journal of the American Chemical Society·Jing ZhengJames S Nowick
Aug 2, 2013·Nature Reviews. Drug Discovery·Gabriella MiklossyJames Turkson
May 31, 2014·BioMed Research International·Soheil Zorofchian MoghadamtousiKeivan Zandi
Jan 1, 2013·Journal of Experimental Pharmacology·Pamela E Potter

❮ Previous
Next ❯

Citations

Mar 6, 2016·European Journal of Medicinal Chemistry·Tarek MohamedPraveen P N Rao
May 18, 2016·ACS Medicinal Chemistry Letters·Tarek MohamedPraveen P N Rao
Apr 6, 2016·European Journal of Medicinal Chemistry·Jean-Pierre JourdanPatrick Dallemagne
Jun 22, 2016·International Journal of Biological Macromolecules·Basir AhmadAnkur P Chaudhary
May 28, 2016·Scientific Reports·Parvez AlamRizwan Hasan Khan
Apr 10, 2017·Biochemical Pharmacology·Paul VelanderBin Xu
Nov 21, 2015·Chemical Communications : Chem Comm·Amit S PithadiaAyyalusamy Ramamoorthy
Jan 25, 2018·International Journal of Molecular Sciences·Botond PenkeLászló Vígh
Jun 15, 2018·Physical Chemistry Chemical Physics : PCCP·Yibo JinGuanghong Wei
Jul 12, 2018·Chemical Communications : Chem Comm·Kevin J Cao, Jerry Yang
Jan 15, 2018·Journal of Alzheimer's Disease : JAD·P Hemachandra ReddyArubala P Reddy
May 4, 2018·Neural Regeneration Research·Min ChenKun Zhang
May 2, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yanxian ZhangJie Zheng
Jun 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesco TavantiMaria Cristina Menziani
Feb 26, 2019·Oxidative Medicine and Cellular Longevity·Rongzi LiJeganathan Ramesh Babu
Mar 9, 2019·Journal of Cellular Physiology·Tahereh FarkhondehMahshid Sedaghat
Mar 20, 2020·International Journal of Molecular Sciences·Stefano MuscatMarco Agostino Deriu
May 20, 2020·Frontiers in Pharmacology·Adhimoolam KarthikeyanTaesun Min
Aug 19, 2018·Scientific Reports·Adree KhondkerMaikel C Rheinstädter
May 17, 2018·Oxidative Medicine and Cellular Longevity·Samra HasanbašićEva Žerovnik
Aug 18, 2017·JCI Insight·Yosef KoronyoMaya Koronyo-Hamaoui
Apr 30, 2017·Journal of Alzheimer's Disease : JAD·Johant Lakey-BeitiaArmando A Durant-Archibold
Jul 22, 2018·Cellular and Molecular Life Sciences : CMLS·Zohra DhouafliInes Moreno-Gonzalez
Aug 25, 2017·Molecular Cancer Therapeutics·Sarah-Grace RotaPaul A Spagnuolo
Jun 27, 2019·The International Journal of Biochemistry & Cell Biology·Sravani PolepalliMahadev Rao
Aug 14, 2021·European Journal of Medicinal Chemistry·Praveen P N RaoFrederic Calon
Mar 21, 2018·ACS Chemical Neuroscience·K RajasekharThimmaiah Govindaraju
Dec 18, 2018·ACS Chemical Neuroscience·Federica BiscegliaFederica Belluti
Dec 21, 2018·The Journal of Physical Chemistry. B·Tye D MartinDeborah G Evans
Aug 15, 2021·Bioorganic & Medicinal Chemistry·Rohmad Yudi UtomoHiroyuki Nakamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.